By Topic

Mining knowledge and data to discover intelligent molecular biomarkers: Prostate cancer i-Biomarkers

Sign In

Cookies must be enabled to login.After enabling cookies , please use refresh or reload or ctrl+f5 on the browser for the login options.

Formats Non-Member Member
$33 $13
Learn how you can qualify for the best price for this item!
Become an IEEE Member or Subscribe to
IEEE Xplore for exclusive pricing!
close button

puzzle piece

IEEE membership options for an individual and IEEE Xplore subscriptions for an organization offer the most affordable access to essential journal articles, conference papers, standards, eBooks, and eLearning courses.

Learn more about:

IEEE membership

IEEE Xplore subscriptions

6 Author(s)
Alexandru Floares ; Department of Artificial Intelligence, SAIA & OncoPredict, Str. Vlahuta Bloc Lama C/45, 400310, Romania ; Ovidiu Balacescu ; Carmen Floares ; Loredana Balacescu
more authors

Currently, there are some paradigm shifts in medicine, from the search for a single ideal biomarker, to the search for panels of molecules, and from a reductionistic to a systemic view, placing these molecules on functional networks. There is also a general trend to favor non-invasive biomarkers. Identifying non-invasive biomarkers in high-throughput data, having thousands of features and only tens of samples is not trivial. Here, we proposed a methodology and the related concepts to develop intelligent molecular biomarkers, via knowledge mining and knowledge discovery in data, illustrated on prostate cancer diagnosis. An informed feature selection is done by mining knowledge about pathways involved in prostate cancer, in specialized data bases. A knowledge discovery in data approach, with soft computing methods, is used to identify the relevant features and discover their relationships with clinical outcomes. The intelligent non-invasive diagnosis systems, is based on a team of mathematical models, discovered with genetic programming, and taking as inputs eight serum angiogenic molecules and PSA. This systems share with other intelligent systems we build, using this methodology but different soft computing techniques, and in different clinical settings - chronic hepatitis, bladder cancer, and prostate cancer - the best published accuracy, even 100%. Soft computing could be a strong foundation for the newly emerging Knowledge-Based-Medicine. The impact on medical practice could be enormous. Instead of offering just hints to the clinicians, like Evidence-Based-Medicine, Knowledge-Based-Medicine which is made possible and co-exists with Evidence-Based-Medicine, offers intelligent clinical decision supports systems.

Published in:

Soft Computing Applications (SOFA), 2010 4th International Workshop on

Date of Conference:

15-17 July 2010